|
1
|
Nagaoka I, Igarashi M and Sakamoto K:
Biological activities of glucosamine and its related substances.
Adv Food Nutr Res. 65:337–352. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Varghese S, Theprungsirikul P, Sahani S,
Hwang N, Yarema KJ and Elisseeff JH: Glucosamine modulates
chondrocyte proliferation, matrix synthesis, and gene expression.
Osteoarthritis Cartilage. 15:59–68. 2007. View Article : Google Scholar
|
|
3
|
Reily C, Stewart TJ, Renfrow MB and Novak
J: Glycosylation in health and disease. Nat Rev Nephrol.
15:346–366. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Block JA, Oegema TR, Sandy JD and Plaas A:
The effects of oral glucosamine on joint health: Is a change in
research approach needed? Osteoarthritis Cartilage. 18:5–11. 2010.
View Article : Google Scholar
|
|
5
|
Agiba AM: Nutraceutical formulations
containing glucosamine and chondroitin sulphate in the treatment of
osteoarthritis: Emphasis on clinical efficacy and formulation
challenges. Int J Curr Pharm Res. 9:1–7. 2017. View Article : Google Scholar
|
|
6
|
Ostojic SM, Arsic M, Prodanovic S, Vukovic
J and Zlatanovic M: Glucosamine administration in athletes: Effects
on recovery of acute knee injury. Res Sports Med. 15:113–124. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
D'Adamo S, Cetrullo S, Panichi V, Mariani
E, Flamigni F and Borzì RM: Nutraceutical activity in
osteoarthritis biology: A focus on the nutrigenomic role. Cells.
9:12322020. View Article : Google Scholar :
|
|
8
|
Ragle RM and Sawitzke AD: Nutraceuticals
in the management of osteoarthritis: A critical review. Drugs
Aging. 29:717–731. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Rovati LC, Girolami F and Persiani S:
Crystalline glucosamine sulfate in the management of knee
osteoarthritis: Efficacy, safety, and pharmacokinetic properties.
Ther Adv Musculoskelet Dis. 4:167–180. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Goldring SR and Goldring MB: Changes in
the osteochondral unit during osteoarthritis: Structure, function
and cartilage-bone crosstalk. Nat Rev Rheumatol. 12:632–644. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Im GI and Kim MK: The relationship between
osteoarthritis and osteoporosis. J Bone Miner Metab. 32:101–109.
2014. View Article : Google Scholar
|
|
12
|
Tat SK, Pelletier JP, Vergés J, Lajeunesse
D, Montell E, Fahmi H, Lavigne M and Martel-Pelletier J:
Chondroitin and glucosamine sulfate in combination decrease the
pro-resorptive properties of human osteoarthritis subchondral bone
osteoblasts: A basic science study. Arthritis Res Ther. 9:R1172007.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Anastassiades T, Rees-Milton K, Xiao H,
Yang X, Willett T and Grynpas M: N-acylated glucosamines for bone
and joint disorders: Effects of N-butyryl glucosamine on
ovariectomized rat bone. Transl Res. 162:93–101. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Igarashi M, Sakamoto K and Nagaoka I:
Effect of glucosamine, a therapeutic agent for osteoarthritis, on
osteoblastic cell differentiation. Int J Mol Med. 28:373–379.
2011.PubMed/NCBI
|
|
15
|
Penolazzi L, Lolli A, Sardelli L,
Angelozzi M, Lambertini E, Trombelli L, Ciarpella F, Vecchiatini R
and Piva R: Establishment of a 3D-dynamic osteoblasts-osteoclasts
co-culture model to simulate the jawbone microenvironment in vitro.
Life Sci. 152:82–93. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Penolazzi L, Pocaterra B, Tavanti E,
Lambertini E, Vesce F, Gambari R and Piva R: Human osteoclasts
differentiated from umbilical cord blood precursors are less prone
to apoptotic stimuli than osteoclasts from peripheral blood.
Apoptosis. 13:553–561. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lambertini E, Penolazzi L, Angelozzi M,
Grassi F, Gambari L, Lisignoli G, De Bonis P, Cavallo M and Piva R:
The expression of cystathionine gamma-lyase is regulated by
estrogen receptor alpha in human osteoblasts. Oncotarget.
8:101686–101696. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wrobel E, Leszczynska J and Brzoska E: The
characteristics of human bone-derived cells (HBDCS) during
osteogenesis in vitro. Cell Mol Biol Lett. 21:262016. View Article : Google Scholar
|
|
19
|
Choudhary S, Sun Q, Mannion C, Kissin Y,
Zilberberg J and Lee WY: Hypoxic three-dimensional cellular network
construction replicates ex vivo the phenotype of primary human
osteocytes. Tissue Eng Part A. 24:458–468. 2018. View Article : Google Scholar :
|
|
20
|
Mandatori D, Penolazzi L, Pipino C, Di
Tomo P, Di Silvestre S, Di Pietro N, Trevisani S, Angelozzi M, Ucci
M, Piva R and Pandolfi A: Menaquinone-4 enhances osteogenic
potential of human amniotic fluid mesenchymal stem cells cultured
in 2D and 3D dynamic culture systems. J Tissue Eng Regen Med.
12:447–459. 2018. View Article : Google Scholar
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
22
|
Takeuchi T, Sugimoto A, Imazato N, Tamura
M, Nakatani S, Kobata K and Arata Y: Glucosamine suppresses
osteoclast differentiation through the modulation of glycosylation
including O-GlcNAcylation. Biol Pharm Bull. 40:352–356. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lv C, Wang L, Zhu X, Lin W, Chen X, Huang
Z, Huang L and Yang S: Glucosamine promotes osteoblast
proliferation by modulating autophagy via the mammalian target of
rapamycin pathway. Biomed Pharmacother. 99:271–277. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Matsubara T, Kinbara M, Maeda T, Yoshizawa
M, Kokabu S and Yamamoto TT: Regulation of osteoclast
differentiation and actin ring formation by the cytolinker protein
plectin. Biochem Biophys Res Commun. 489:472–476. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Luukkonen J, Hilli M, Nakamura M, Ritamo
I, Valmu L, Kauppinen K, Tuukkanen J and Lehenkari P: Osteoclasts
secrete osteopontin into resorption lacunae during bone resorption.
Histochem Cell Biol. 151:475–487. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chapurlat RD and Confavreux CB: Novel
biological markers of bone: From bone metabolism to bone
physiology. Rheumatology (Oxford). 55:1714–1725. 2016. View Article : Google Scholar
|
|
27
|
Jiang Z, Li Z, Zhang W, Yang Y, Han B, Liu
W and Peng Y: Dietary natural N-Acetyl-d-Glucosamine prevents bone
loss in ovariectomized rat model of postmenopausal osteoporosis.
Molecules. 23:23022018. View Article : Google Scholar :
|
|
28
|
Ivanovska N and Dimitrova P: Bone
resorption and remodeling in murine collagenase-induced
osteoarthritis after administration of glucosamine. Arthritis Res
Ther. 13:R442011. View
Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang SX, Laverty S, Dumitriu M, Plaas A
and Grynpas MD: The effects of glucosamine hydrochloride on
subchondral bone changes in an animal model of osteoarthritis.
Arthritis Rheum. 56:1537–1548. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Feng X and McDonald JM: Disorders of bone
remodeling. Annu Rev Pathol. 6:121–145. 2011. View Article : Google Scholar
|
|
31
|
Kim BJ and Koh JM: Coupling factors
involved in preserving bone balance. Cell Mol Life Sci.
76:1243–1253. 2019. View Article : Google Scholar
|
|
32
|
Nasri H, Baradaran A, Shirzad H and
Rafieian-Kopaei M: New concepts in nutraceuticals as alternative
for pharmaceuticals. Int J Prev Med. 5:1487–1499. 2014.
|
|
33
|
Daliu P, Santini A and Novellino E: From
pharmaceuticals to nutraceuticals: Bridging disease prevention and
management. Expert Rev Clin Pharmacol. 12:1–7. 2019. View Article : Google Scholar
|
|
34
|
Felson DT: Concerns about report
suggesting glucosamine and chondroitin protect against cartilage
loss. Ann Rheum Dis. 74:e382015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yang X and Qian K: Protein
O-GlcNAcylation: Emerging mechanisms and functions. Nat Rev Mol
Cell Biol. 18:452–465. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Herrero-Beaumont G and Largo R:
Glucosamine and O-GlcNAcylation: A novel immunometabolic
therapeutic target for OA and chronic, low-grade systemic
inflammation? Ann Rheum Dis. 79:1261–1263. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Koyama T and Kamemura K: Global increase
in O-linked N-acetylglucosamine modification promotes osteoblast
differentiation. Exp Cell Res. 338:194–202. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Hart GW, Slawson C, Ramirez-Correa G and
Lagerlof O: Cross talk between O-GlcNAcylation and phosphorylation:
Roles in signaling, transcription, and chronic disease. Annu Rev
Biochem. 80:825–858. 2011. View Article : Google Scholar : PubMed/NCBI
|
